Accession Number: | 0001209191-19-003500 |
Date: | 2019-01-10 |
Issuer: | AMARIN CORP PLC\UK (AMRN) |
Original Submission Date: |
ZAKRZEWSKI JOSEPH S
C/O AMARIN PHARMA, INC.
1430 ROUTE 206
BEDMINSTER, NJ 07921
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2019-01-10 | M | 200,000 | a | $3.40 | 284,547 | direct | ||
ORDINARY SHARES | 2019-01-10 | S | 100,000 | d | $16.00 | 184,547 | direct | ||
ORDINARY SHARES | 2019-01-10 | S | 100,000 | d | $17.96 | 84,547 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 3.4 | 2019-01-10 | deemed execution date | M | 200,000 (d) | 2020-11-11 | ordinary shares 200,000 | $3.40 | 500,000 | direct |
ID | footnote |
---|---|
f1 | the option exercises and sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | the ordinary shares may be represented by american depositary shares, each of which currently represents one ordinary share. |
f3 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $15.90 to $16.44, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
f4 | the price reported in column 4 is a weighted average price. these shares were sold in multiple transactions at prices ranging from $17.90 to $18.10, inclusive. the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the securities and exchange commission, upon request, full information regarding the number of shares sold at each separate price within the range. |
f5 | the stock option granted to the reporting person is fully vested as of the date hereof. |